Found 1,117 investors
Josep Aliagas
United States
Ms. Sujatha Kumar is a Co-Founder and serves as Managing Partner at Ayatis. She has over 25 years of domestic and international experience in directing high-growth Technology, Consulting and Manufacturing companies in senior leadership roles. Her experience includes General Management, and International Sales and Marketing. Sujatha's current focus is on operationalizing Industrial Internet of Things technologies in Oil & Gas, Mining and Manufacturing. She has led Technology and Consulting groups through delivering IIoT business and process models to deliver results. Sujatha has a Masters in Computer Science from the Loyola University of Maryland and an MBA from Rice University.
Individual/Angel
Joshua Funder
Melbourne, Victoria, Australia
Joshua Funder joined GBS Partners in 2004 and has more than 17 years of experience in biotechnology research, management and venture investi...
Investment Partner
Joshua Stech
United Kingdom
Mr. Andre Crawford-Brunt serves as Member at 24Haymarket. He also serves as General Partner at Braavos Investment Advisers, as Board Member at Osler Diagnostics, SpyBiotech and Q-Branch Labs and Synbiosys, as Non-Executive Director at Oxford Sciences Innovation & as Partner at Sansa Advisors. He served as the former Global Head of Equity Trading for Deutsche Bank. He is also an Angel Investor. He served as Board Member of Ultromics.
Individual/Angel
J.R. Kraft
Israel
Dr. Max Herzberg is a Co-Founder of PixCell Medical Technologies. He also is an Angel Investor. He is also the Founder and serves as Chief Executive Officer and Chairman at Vidac Pharma. He is a well-known scientist and entrepreneur and one of the founding fathers of the Israel life sciences industry. He founded Orgenics and the EagerBio Group, is the co-founder of PixCell, and served as chairman of several biotechnology companies in Israel and as chairman of the European Molecular Biology Laboratory Enterprise Management (Heidelberg, Germany). He holds a Ph.D. in Molecular Biology from the Weizmann Institute of Science. He is a well-known scientist and entrepreneur and one of the founding fathers of the Israel life sciences industry. He founded Orgenics and the EagerBio Group, served as chairman of several biotechnology companies in Israel and as chairman of the European Molecular Biology Laboratory Enterprise Management (Heidelberg, Germany). He is currently the active chairman of Vidac Pharma.
Individual/Angel
J. Sassoon Group
United States
Found in 2020, J.Sassoon Group is a private equity firm based in Washington DC, United States. The firm prefers to invest in technology, biotechnology and life sciences, mining, renewable and clean energy, and commercial real estate.
Private Equity Firm
Juan Capurro Boltendahl
Madrid, Madrid, Spain
International Investment Banker, M&A and Venture Capital specialist, Pharma & Biotech sector expertise. Over 20 years international Inve...
Investment Partner
Julian Von Hassell
Germany
Mr. Julian Von Hassell is an Angel Investor. He has been working continuously in the German start-up and venture capital scene as a serial entrepreneur. His focus as an angel is on early-stage B2B technology startups with an initial track record. His industry focus is currently on IIoT, data analytics, b2b platform tools, e-health and 3D. He studied philosophy, logic, philosophy of science and history in Munich (LMU) and Cambridge and graduated in 1985 with a Master of Philosophy in philosophy of science and history of science from Cambridge University (Hughes Hall).
Individual/Angel
Julien Boubel
United States
Mr. Frederick Dotzler is a Co-Founder and serves as Managing Director at De Novo Ventures. He is also a co-founder of De Novo. Prior to De Novo, he was a Managing General Partner of Medicus Venture Partners ("Medicus"), which he founded in 1989. Medicus was an early stage investor in companies such as Anergen, Applied Molecular Evolution, Biosite Diagnostics, Inhale Therapeutic Systems (now Nektar), Omnicell and Tularik. Prior to Medicus, he was a General Partner with Crosspoint Venture Partners for 5 years, where he invested in life sciences companies. Prior to joining Crosspoint, Fred served in executive positions in finance, marketing, sales, manufacturing and business development for companies selling pharmaceuticals (Searle), medical instruments (Merrimack), biotechnology research tools (Millipore), and computers (IBM). Fred earned an MBA from the University of Chicago, a Masters equivalent in Economics from the University of Louvain, Belgium and a BS in Engineering from Iowa State University, where he received a Professional Achievement Citation in Engineering in 2000. He represented or represents De Novo Ventures on investments in Astute Medical, Microvention, Oncomed, Renovis and Senorx. Fred is a Trustee of the Salk Institute, a Trustee of the Santa Fe Institute, an Advisor to the Gruter Institute, and a member of the Advisory Board of the Journal of Private Equity. He is also an investor of Personalis.
Individual/Angel
Jumpstart Nova
United States
Founded in 2020, Jumpstart Nova is a venture capital firm based in Nashville, Tennessee. The firm seeks to invest in Black founder-led healthcare companies across health IT, digital health, tech-enabled services, diagnostic devices, biotech, medical device manufacturing, and consumer health and wellness sectors across the United States.
Venture Capital
Juning Venture Capital
China
Founded in 2008, Juning Venture Capital is the corporate venture arm of Juning Group based in Jiangsu, China. The firm seeks to make investments in sectors like renewable energy, advanced material, information technology, and biotechnology.
Venture Capital
Justin Szlasa
United States
Mr. Elliot Wagner served as Managing Director at The Carlyle Group. He also served as Board Member at The Bountiful Company. He also is an Angel Investor. He is based in New York. From 2000 to 2008, Mr. Wagner was based in Carlyle's Washington, D.C. office as a member of the Global Aerospace, Defense and Government Services Group. He played a key role in the execution of Carlyle's investments in Sequa Corp., Wesco Aircraft, Piedmont Hawthorne/Garrett Aviation, Avio SpA and Communications & Power Industries and was also actively involved with the management of the firm's investments in US Investigations Services and United Defense Industries. Prior to joining Carlyle, Mr. Wagner was a Financial Analyst in the Mergers & Acquisitions Group of Lehman Brothers, where he focused on transactions in the industrial, aerospace, defense and technology sectors. Mr. Wagner graduated with distinction from Cornell University, where he received a B.S. in economics and business management. Mr. Wagner is a member of the Board of Directors of Wesco Holdings Inc. and Sequa Corp.
Individual/Angel
K2 Biotechnology Ventures
United States
Founded in 2017, K2 Biotechnology Ventures is an investment firm based in the United States. The firm seeks to invest in companies operating in the biotech and healthcare sectors.
Venture Capital
Karl Weaver
Sweden
Mr. Lars Molinder serves as Group Head of the Healthcare Sector at Carnegie Investment Bank in Sweden. He is an Angel Investor. He serves as a Board member at Oblique Therapeutics. He served as Board Member at Ondek. He has over 15 years of financial sector experience working solely with companies in the healthcare sector. Lars has been the Head of Medicine and Biotechnology at the Swedish Industrial Development Fund and made over 40 investments in early stage companies ranging from medical technology and diagnostics to pharmaceuticals and biotechnology. Prior to joining Carnegie Investment Bank, Lars was the Nordic Head of Healthcare Sector and European co-Head of Healthcare Banking at Alfred Berg and ABN AMRO. Selected recent deals include: defence adviser to Gambro (PTP) and Biacore (PTP), and sole lead manager for the initial public offering of Clavis Pharma, Orexo and Biovitrum. Lars has a M.Sc. in Engineering.
Individual/Angel
KBC Focus Fund
Brussels, Brussels Hoofdstedelijk Gewest, Belgium
The VC fund of KBC for companies active in the domain of Micro Electronics, IOT and Nanotechnology
Information Technology
Manufacturing
Venture Capital
Keith Timimi
Israel
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. The firm invests in new biotechnology products.
Accelerator
Incubator
Kelli Turner
United States
Mr. Lowell Sears serves as Chairman, Chief Executive Officer and Chief Investment Officer at Sears Capital Management. He served as Board Member at Halcyon Medical. He also serves as a Board Member at Vital Therapies. He has served on the board of directors of Cellerant Therapeutics, Inc., a clinical stage biotechnology company focused on the regulation of the hematopoietic, or blood-forming, system, since February 2012 and has been Chairman of the Board since June 2012. Mr. Sears has also served on the board of directors of SymBio Pharmaceuticals, KK, Ltd., a biotechnology company that is engaged in identifying and developing therapeutics for the treatment of leukemia, multiple myeloma and lymphoma, since September 2005. From 1986 until 1994, Mr. Sears was a part of the senior management team of Amgen, Inc., a developer and manufacturer of therapeutics targeting cancers, kidney ailments, inflammatory disorders, and metabolic diseases, where he was Chief Financial Officer as well as the Senior Vice President responsible for the Asia Pacific Region. Prior to joining Amgen, Mr. Sears held senior planning and financial positions with Atlantic Richfield Company, an oil company from 1976 until 1986, including Chief Financial Officer for its Ventures Division. He earned a B.A. in economics from Claremont McKenna College and an M.B.A. from the Stanford University Graduate School of Business.
Individual/Angel
Kendall Capital Partners
United States
Founded in 2021, Kendall Capital Partners is a venture capital firm based in Boston, Massachusetts. The firm prefers to make early-state investments in biotech companies (platform biotechnology, drug delivery, diagnosis, novel drugs).
Venture Capital
Kenn Koid
India
Dr. Donald Brown is a Co-Founder and serves as Chief Executive Officer at Lifeomic. Dr. Donald Brown is the Founder of Interactive Intelligence Group and also serves as its Chairman of the Board, President and Chief Executive Officer. He co-founded his third software company, Interactive Intelligence, in October 1994. He has been a director since inception. In March 1988, Dr. Brown co-founded Software Artistry, Inc., a developer of customer support software that became a public company in March 1995 and was subsequently acquired by IBM Corporation in January 1998. At Software Artistry, Dr. Brown served as Chief Executive Officer and director from inception through September 1994. Dr. Brown's first software company was acquired by Electronic Data Systems, Inc. in September 1987. Dr. Brown graduated from the Indiana University School of Medicine in 1985. He also holds two additional degrees from Indiana University, an M.S. in computer science and a B.S. in physics. Dr. Brown is currently completing an M.S. in Biotechnology at Johns Hopkins University. He is the father of eight children and an avid pilot and rock climber.
Individual/Angel
KensaGroup
United States
Founder in 2000, KensaGroup is a venture capital firm that creates, launches and develops leading-edge platform discoveries from universities and corporate research laboratories within the framework of startup ventures. It prefers to invest in companies operating in the biotech, chemical, material, energy, medical device, pharmaceutical, financial services, agriculture, electronics and automotive sectors. The firm is headquartered in Ithaca, New York.
Strategic Acquirer
Keren-Yam
Israel
Founded in 2022, Keren-Yam is a venture capital firm based in Tel-Aviv, Israel. The firm seeks to build and invest in companies operating in the marine biotechnology, aquaculture, technology and sustainability sectors.
Venture Capital
Showing 621 to
640 of
1,117 results